Japan’s Astellas to buy Iveric Bio for $5.9 billion to expand eyesight treatments By Reuters Finances May 1, 2023 [ad_1] © Reuters. FILE PHOTO: Astellas Pharma’s brand is pictured at its headquarters in Tokyo, Japan, December 3, 2019. REUTERS/Kim…
